Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion

35Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Background: Malignant pleural mesothelioma (MPM) is a rare but fatal tumour. Although most MPM patients show pleural effusion at even the early stage, it is hard to diagnose as MPM at the early stage because a sensitive and reliable diagnostic marker for MPM has not been found in plasma or pleural effusion. Methods: In this study, we investigated whether intelectin-1 was specifically contained in MPM cells and the pleural effusion of MPM patient by immunohistochemistry, western blotting, and enzyme-linked immunosorbent assay. Results: Malignant pleural mesothelioma cell lines, but not lung adenocarcinoma cell lines, secreted intelectin-1. In immunohistochemistry, epithelioid-type MPMs, but neither pleura-invading lung adenocarcinomas nor reactive mesothelial cells near the lung adenocarcinomas, were stained with anti-intelectin antibodies. Pleural effusion of MPM patients contained a higher concentration of intelectin-1 than that of lung cancer patients.Conclusion:These results suggest that detection of intelectin-1 may be useful for a differential diagnosis of epithelioid-type MPM in immunohistochemistry and that a high concentration of intelectin-1 in pleural effusion can be used as a new marker for clinical diagnosis of MPM. © 2010 Cancer Research UK All rights reserved.

Cite

CITATION STYLE

APA

Tsuji, S., Tsuura, Y., Morohoshi, T., Shinohara, T., Oshita, F., Yamada, K., … Miyagi, Y. (2010). Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. British Journal of Cancer, 103(4), 517–523. https://doi.org/10.1038/sj.bjc.6605786

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free